Trials / Unknown
UnknownNCT03959280
CPAP, Nutrition & Exercise Against Sleep Apnea
Tailored Intervention on Nutrition and Exercise for Obstructive Sleep Apnea Patients Treated With CPAP
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Raphael Heinzer · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates the addition of a comprehensive lifestyle program including dietary management and exercise to continuous positive airway pressure (CPAP) therapy in overweighted adults with obstructive sleep apnea. Half of the participants will receive CPAP therapy while the other half will have diet consultations, nordic walking sessions and CPAP.
Detailed description
While the specific impact of obstructive sleep apnea (OSA) on quality of life is well established, the impact of CPAP therapy on quality of life remains unclear. Yet, improving the quality of life of OSA patient is one of the main targets of treatment. Both exercise and healthy diet are recommended in the management of overweight and obesity. This should improve quality of life as well as comorbidities associated with sleep apnea.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Tailored intervention | * The exercise program consists of 2 x 1.5-hour supervised nordic walking sessions weekly during 12 weeks and 1-hour unsupervised moderate physical activity per week from week 4. * The diet intervention includes one face-to-face consultation with a dietician and one telephone-based contact monthly, i.e. 6 diet interventions for 12 weeks. * Behavioural changes techniques will be included in diet and exercise interventions. |
| OTHER | Control | This intervention will include tailored instruction on CPAP use and standard advices on physical activity and nutrition at CPAP initiation. |
Timeline
- Start date
- 2019-08-21
- Primary completion
- 2022-12-01
- Completion
- 2022-12-01
- First posted
- 2019-05-22
- Last updated
- 2021-08-09
Locations
2 sites across 2 countries: France, Switzerland
Source: ClinicalTrials.gov record NCT03959280. Inclusion in this directory is not an endorsement.